Stockreport

Will Positive Nomlabofusp Study Results Alter Larimar Therapeutics' (LRMR) Standing in Rare Disease Treatment? [Yahoo! Finance]

Larimar Therapeutics, Inc.  (LRMR) 
PDF Friedreich's Ataxia, showing benefits at both 25 mg and 50 mg doses through daily subcutaneous self-injection. This development marks a significant step for Larimar in [Read more]